Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a novel class of drugs that have recently gained popularity for their ability to effectively manage type 2 diabetes mellitus and promote weight loss by delaying gastric emptying. This evidence concerns the gene GLP1R and diabetes mellitus.